Related Experiment Video

Updated: Jul 19, 2026

Mapping Dysfunctional Protein-Protein Interactions in Disease
09:39

Mapping Dysfunctional Protein-Protein Interactions in Disease

Published on: October 24, 2025

ID proteins as targets in cancer and tools in neurobiology

Antonio Iavarone1, Anna Lasorella

  • 1Institute for Cancer Genetics, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.

Trends in Molecular Medicine
|October 31, 2006
PubMed

Insights

ID proteins regulate development and promote tumor progression by maintaining stem cell traits. In neurons, they prolong axon growth, revealing novel therapeutic avenues for cancer and neurological disorders.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Cancer Biology

Background:

  • ID proteins are crucial regulators in eukaryotic development, maintaining stem cell pluripotency and inhibiting differentiation.
  • Aberrant ID protein activity drives tumorigenesis by promoting cancer cell proliferation, invasion, angiogenesis, and metastasis.
  • ID proteins confer embryonic stem cell-like properties to cancer cells through oncogenic activation.

Purpose of the Study:

  • To explore the dual role of ID proteins in tumorigenesis and neuronal development.
  • To discuss the unique functions of ID proteins in post-mitotic neurons, specifically in axon growth.
  • To highlight potential therapeutic strategies arising from the distinct properties of ID proteins in cancer and neurons.

Main Methods:

  • Review of existing literature on ID protein function in development, cancer, and neuroscience.
  • Analysis of oncogenic pathways leading to aberrant ID protein activation in tumors.
  • Investigation of ID protein-mediated regulation of axonal elongation in post-mitotic neurons.

Main Results:

  • ID proteins are implicated in multiple stages of tumor progression, including proliferation and metastasis.
  • In post-mitotic neurons, elevated ID protein levels sustain axon growth and prevent growth cessation.
  • ID proteins exhibit context-dependent functions, acting as oncogenes in cancer and regulators of neuronal plasticity.

Conclusions:

  • The distinct roles of ID proteins in cancer cells and neurons present unique therapeutic opportunities.
  • Targeting ID proteins could offer novel strategies for treating both cancer and neurological conditions.
  • Understanding ID protein regulation is key to developing innovative therapeutic interventions.

More Related Videos

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue11:49

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...